Eiji Nakano

35PUBLICATIONS
92CO-AUTHORS
NanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunityMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jul 07, 2026
Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.

|Mar 27, 2026
Docetaxel for Pembrolizumab-Refractory Recurrent Basal Cell Carcinoma.

Yoshiki Sakai, Dai Ogata, Michitoshi Kurisaki

|Mar 03, 2026
Efficacy and safety of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma in Japan: Results of the Japan Clinical Oncology Group single-arm confirmatory trial (JCOG1605).

Kohei Oashi, Dai Ogata, Masayuki Yokoyama

|Jan 05, 2026
Efficacy of adjuvant anti-PD-1 antibody versus observation for resected nail apparatus melanoma.

Takaya Komori, Eiji Nakano, Yukiko Kiniwa

|Dec 05, 2025
Treatment Outcomes of Surgery and ICI Therapy in 52 Patients With Esophageal Melanoma: A Retrospective Single-Center Cohort Study.

Akihiro Ishiguro, Dai Ogata, Koshiro Ishiyama

|Oct 28, 2025
Response to Crizotinib in ROS1 Fusion-Positive Metastatic Angiosarcoma of the Scalp: A Case Report.

Yuichi Nakayama, Dai Ogata, Eiji Nakano

Pageof 6

Frequent Collaborators

25 joint publications

Kenjiro Namikawa

24 joint publications

Naoya Yamazaki

21 joint publications

Dai Ogata

6 joint publications

Chikako Nishigori